Biocon share price jumped over 4% to a fresh 52-week high on Thursday after reports stated that the company was evaluating an internal merger of its biosimilars arm, Biocon Biologics, with the parent ...

Biocon Ltd. shares gained in early trade on Monday, December 16, after the company announced the launch of its Glucagon-like Peptide-1 (GLP-1) for diabetes and obesity in the Netherlands via its ...

Biocon Limited witnessed a gain of over 2% in its stock price in Wednesday morning trade after its subsidiary announced that its commercial partner in Japan launched the Ustekinumab BS Subcutaneous.

Biocon to acquire stakes via share swaps with Serum Institute, Tata Capital, Activ Pine Shreehas Tambe to lead combined entity as CEO, managing director Biocon reviewed IPO, merger options before ...

Biocon Ltd will integrate Biocon Biologics Ltd as a wholly owned subsidiary in a deal valuing the unit at $5.5 billion, the company said on Saturday. Biocon will acquire the remaining stake in Biocon ...

Bengaluru-headquartered biopharmaceutical major Biocon has announced that it is to fully integrate Biocon Biologics Limited (BBL) as a wholly owned subsidiary into Biocon Limited. Describing it as a ...

The road to certification for Biocon’s insulin facility in Malaysia was long, winding and full of potholes. Now comes a detour. The FDA has slapped the factory with Form 483, citing six observations ...

Biocon has announced that it is to fully integrate Biocon Biologics Limited Biocon share price is in focus today after the company announced a major restructuring move involving its biologics business ...

USD 5.5 billion deal: Biocon, an innovation-driven global biopharmaceuticals company, on Saturday, December 6 2025, announced a strategic move to fully integrate Biocon Biologics Limited (BBL) as a ...

Biocon—controlled by Indian pharmaceutical billionaire Kiran Mazumdar-Shaw—is buying the rest of privately held subsidiary Biocon Biologics to consolidate its biosimilars and generics drug businesses.

Biocon on Saturday announced that it will fully integrate its biosimilars arm Biocon Biologics Limited (BBL) into the parent company. The company said the move is aimed at creating a unified biopharma ...

BENGALURU, Dec 6 (Reuters) - Indian biopharmaceutical company Biocon said on Saturday it would fully integrate its biosimilar unit Biocon Biologics as a wholly owned subsidiary, consolidating Biocon’s ...